Used primarily in the synthesis of pharmaceutical intermediates, particularly in the development of anticoagulant drugs. It serves as a key building block in the preparation of factor Xa inhibitors, which are important for preventing blood clots in patients with cardiovascular conditions. Its structure allows for strong interactions with biological targets, enhancing drug efficacy. Commonly employed in medicinal chemistry for modifying pharmacokinetic properties such as solubility and bioavailability. Also utilized in research settings for developing new bioactive molecules and in the optimization of drug candidates targeting thrombosis and related disorders.